Does TOCILIZUMAB Cause Nephrolithiasis? 553 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 553 reports of Nephrolithiasis have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.6% of all adverse event reports for TOCILIZUMAB.
553
Reports of Nephrolithiasis with TOCILIZUMAB
0.6%
of all TOCILIZUMAB reports
2
Deaths
281
Hospitalizations
How Dangerous Is Nephrolithiasis From TOCILIZUMAB?
Of the 553 reports, 2 (0.4%) resulted in death, 281 (50.8%) required hospitalization, and 13 (2.4%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
Yes, Nephrolithiasis is listed as a known adverse reaction in the official FDA drug label for TOCILIZUMAB.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which TOCILIZUMAB Alternatives Have Lower Nephrolithiasis Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE